TJX vs TPST · P/E 32, rev $29.50B vs $26.3M cap
The TJX Companies Inc (TJX) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
TPST does not have a complete income-statement cache yet.
TJX currently screens at market cap $181.32B and trailing P/E 31.9. TPST currently screens at market cap $26.3M.
Not investment advice. Open the TJX and TPST stock pages for the full models.
Not investment advice.